课题基金基金详情
基于VEGF信号通路探讨重组FOXN1蛋白对新生儿败血症动物模型的保护作用及机制
结题报告
批准号:
81601324
项目类别:
青年科学基金项目
资助金额:
17.5 万元
负责人:
刘亚兰
依托单位:
学科分类:
H0421.新生儿相关疾病
结题年份:
2019
批准年份:
2016
项目状态:
已结题
项目参与者:
陈燕、郑芳、蔡馥丞、杜小弋、张冰玉、王劲、谷叶莲
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
感染是新生儿死亡的首要病因之一。胸腺病理性退化导致的免疫反应低下在新生儿败血症发生发展中起关键作用。我们前期研究发现:转录因子FOXN1具有促进胸腺上皮细胞(TECs)增殖、介导胸腺重建进而增强机体免疫功能的作用;新生儿败血症动物模型中胸腺FOXN1表达下调,伴有血管内皮生长因子(VEGF)通路表达平行下降。因此,我们推测FOXN1在新生儿感染胸腺发育、退化及重建过程中具有重要作用,VEGF是FOXN1的关键调控靶点。本课题拟应用前期克隆表达纯化的重组FOXN1(rFOXN1)蛋白,选用败血症新生动物模型及离体TECs,研究rFOXN1蛋白对胸腺结构和功能的影响,并探索其对退化胸腺的重建作用和对败血症的治疗效果;继而阻断VEGF信号通路,进一步探讨VEGF信号通路在rFOXN1蛋白调控机制中的作用。本课题将为新生儿败血症治疗,降低该病死亡率提供新的思路和途径。
英文摘要
Newborn are highly susceptible to infection, which remains important to neonatal mortality. Thymus involution plays a major role in the process of neonatal sepsis. The transcription factor Forkhead box N1 (FOXN1) is a master regulator in the development of thymic epithelial cells (TECs), and the activation of endogenous Foxn1 is as part of an initiated TEC differentiation program to enhancing immune system function. We found the expression of FOXN1 significantly decreased in the animal model of neonatal sepsis. We successfully cloned and expressed recombinant FOXN1 protein (rFOXN1) that was fused with cell-penetrating peptides. And we showed that administration of rFOXN1 into hematopoietic stem cell transplantation mice increased the number of TECs, promoted T cell regeneration and adaptive immunity. We also found that vascular endothelial growth factor(VEGF) of thymus contributed to the development of TECs in neonatal sepsis. So we hypothesize that FOXN1 is required not only for thymus development, but also for thymus involution and regeneration in neonatal sepsis, and VEGF pathway is involved. In this topic, we intend to apply the pre-purification rFOXN1 protein in vivo and in-vitro of neonatal sepsis models, to study the effect of rFOXN1 protein on the structure and function of the thymus, and explore its effect on thymus regeneration and the treatment of sepsis. Furthermore blocking the VEGF signaling pathway, we further explore the protective effect of rFOXN1 protein. This project will provide new ideas and approaches in neonatal sepsis treatment and reduce the mortality rate of the disease.
新生儿败血症出现胸腺病理性退化,影响胸腺中枢免疫和T细胞免疫,寻求促进胸腺重建的方法,减少感染导致的免疫抑制,是切断败血症应激级联反应的有效途径。转录因子FOXN1具有促进胸腺上皮细胞(TECs)增殖、介导胸腺重建进而增强机体免疫功能的作用。本课题选用败血症新生动物模型,通过研究胸腺结构、胸腺功能以及炎症因子水平,并拮抗VEGF的表达。研究结果显示,新生儿胸腺FOXN1和VEGF的基因表达与成人存在明显差异,新生儿高表达FOXN1和VEGF。感染时新生鼠FOXN1 和VEGF蛋白表达降低,TECs和胸腺细胞成熟障碍,脾细胞CD4+、CD8+明显减少。VEGF是FOXN1的关键调控靶点。rFOXN1 蛋白可促进TECs 分化,增加胸腺细胞和成熟T细胞数量,部分恢复胸腺功能,减轻机体炎症因子水平。本课题目前和进一步的研究成果,将阐明新生儿败血症免疫治疗的重要作用及机制的初步探讨,为降低该病死亡率提供新的思路。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
(Pro)renin receptor regulates lung development via the Wnt/β-catenin signaling pathway
(Pro) 肾素受体通过 Wnt/β-catenin 信号通路调节肺发育
DOI:10.1152/ajplung.00295.2018
发表时间:2019-08-01
期刊:AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
影响因子:4.9
作者:Liu, Jie;Zhou, Yafan;Peng, Hua
通讯作者:Peng, Hua
Thioredoxin-1 Protects Bone Marrow-Derived Mesenchymal Stromal Cells from Hyperoxia-Induced Injury In Vitro.
Thioredoxin-1 保护骨髓来源的间充质基质细胞免受高氧诱导的体外损伤
DOI:10.1155/2018/1023025
发表时间:2018
期刊:Oxidative medicine and cellular longevity
影响因子:--
作者:Zhang L;Wang J;Chen Y;Zeng L;Li Q;Liu Y;Wang L
通讯作者:Wang L
Infants Born to Mothers With a New Coronavirus (COVID-19)
患有新型冠状病毒 (COVID-19) 的母亲所生的婴儿
DOI:10.3389/fped.2020.00104
发表时间:2020-03-16
期刊:FRONTIERS IN PEDIATRICS
影响因子:2.6
作者:Chen, Yan;Peng, Hua;Liu, Yalan
通讯作者:Liu, Yalan
国内基金
海外基金